| |
 |
|
Class Information
Number: 424/189.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Hepatitis virus
Description: Subject matter wherein the virus is a hepatitis virus.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615228 |
Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits |
Nov. 10, 2009 |
| 7611713 |
Inducing cellular immune responses to hepatitis B virus using peptide compositions |
Nov. 3, 2009 |
| 7608274 |
Therapeutic processes and useful compositions therefor |
Oct. 27, 2009 |
| 7579003 |
HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof |
Aug. 25, 2009 |
| 7556815 |
Hepatitis B virus surface antigen mutant and methods of detection thereof |
Jul. 7, 2009 |
| 7504560 |
Vaccines expressed in plants |
Mar. 17, 2009 |
| 7485312 |
Surface protein (HBsAg) variant of the hepatitis B virus |
Feb. 3, 2009 |
| 7439347 |
Hepatitis C virus non-structural NS3/4A fusion gene |
Oct. 21, 2008 |
| 7413741 |
HCV E1 comprising specific disulfide bridges |
Aug. 19, 2008 |
| 7405039 |
Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
Jul. 29, 2008 |
| 7402315 |
Hepatitis-C virus type 4, 5 and 6 |
Jul. 22, 2008 |
| 7393831 |
Peptide compositions and their use against HCV |
Jul. 1, 2008 |
| 7378234 |
Method for isolating hepatitis C virus peptides |
May. 27, 2008 |
| 7374766 |
Compositions containing virus-like particles as immunopotentiators administered through the mucosa |
May. 20, 2008 |
| 7368118 |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
May. 6, 2008 |
| 7361352 |
Influenza immunogen and vaccine |
Apr. 22, 2008 |
| 7351413 |
Stabilized HBc chimer particles as immunogens for chronic hepatitis |
Apr. 1, 2008 |
| 7351570 |
HDV nucleic acid molecules and applications thereof |
Apr. 1, 2008 |
| 7348011 |
Hepatitis C virus vaccine |
Mar. 25, 2008 |
| 7341726 |
Modified HCV peptide immunogens |
Mar. 11, 2008 |
| 7341723 |
Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
Mar. 11, 2008 |
| 7320795 |
Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof |
Jan. 22, 2008 |
| 7319144 |
Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay |
Jan. 15, 2008 |
| 7314925 |
Constructs and methods for expression of recombinant HCV envelope proteins |
Jan. 1, 2008 |
| 7313357 |
Method for typing and detecting HBV |
Dec. 25, 2007 |
| 7307066 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
Dec. 11, 2007 |
| 7291723 |
GB virus C and methods of treating viral infections |
Nov. 6, 2007 |
| 7285539 |
Activation of HCV-specific T cells |
Oct. 23, 2007 |
| 7270820 |
CD4+ T-lymphocyte-specific hepatitis C virus epitopes |
Sep. 18, 2007 |
| 7264811 |
Purified active HCV NS2/3 protease |
Sep. 4, 2007 |
| 7255864 |
Diagnostic reagent for hepatitis C virus infection |
Aug. 14, 2007 |
| 7252827 |
Conserved motif of hepatitis C virus E2/NS1 region |
Aug. 7, 2007 |
| 7241440 |
Vaccines containing ribavirin and methods of use thereof |
Jul. 10, 2007 |
| 7238356 |
Core-glycosylated HCV envelope proteins |
Jul. 3, 2007 |
| 7226599 |
Diagnostic reagent for hepatitis C virus infection |
Jun. 5, 2007 |
| 7201904 |
Epitopes of hepatitis C virus |
Apr. 10, 2007 |
| 7201911 |
Cloned genomes of infectious hepatitis C viruses and uses thereof |
Apr. 10, 2007 |
| 7202354 |
Hepatitis B virus surface antigen mutant and methods of detection thereof |
Apr. 10, 2007 |
| 7198892 |
Hepatitis-C virus type 4, 5 and 6 |
Apr. 3, 2007 |
| 7195765 |
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
Mar. 27, 2007 |
| 7189810 |
Polypeptides, use thereof and process for producing the same |
Mar. 13, 2007 |
| 7166287 |
Viral agent |
Jan. 23, 2007 |
| 7166426 |
HCV assay |
Jan. 23, 2007 |
| 7144712 |
Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof |
Dec. 5, 2006 |
| 7141242 |
Hepatitis B virus surface antigen mutant and methods of detection thereof |
Nov. 28, 2006 |
| 7138514 |
Hepatitis B virus surface antigen mutant and methods of detection thereof |
Nov. 21, 2006 |
| 7135185 |
Conserved motif of hepatitis C virus E2/NS1 region |
Nov. 14, 2006 |
| 7118874 |
Immunogenic formulation and process for preparation thereof |
Oct. 10, 2006 |
| 7108856 |
CD4.sup.+ T-lymphocyte-specific Hepatitis C virus-epitopes |
Sep. 19, 2006 |
| 7105165 |
Mutant human hepatitis B viral strain and uses thereof |
Sep. 12, 2006 |
|
|
|
